| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 257 | 965 | 2.931 | 4.610 | 7.428 | 32.761 | 47.970 | 58.213 | 78.429 |
| Total Income - EUR | - | 257 | 965 | 2.931 | 4.610 | 7.428 | 32.761 | 47.970 | 58.256 | 78.429 |
| Total Expenses - EUR | - | 279 | 53 | 68 | 119 | 66 | 372 | 18.408 | 31.187 | 41.147 |
| Gross Profit/Loss - EUR | - | -22 | 912 | 2.863 | 4.491 | 7.362 | 32.389 | 29.562 | 27.069 | 37.282 |
| Net Profit/Loss - EUR | - | -30 | 882 | 2.753 | 4.352 | 7.150 | 31.406 | 28.102 | 19.597 | 32.671 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hematomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 71.251 | 50.244 | 29.289 |
| Current Assets | - | 310 | 1.189 | 4.030 | 8.333 | 15.247 | 46.425 | 29.519 | 50.263 | 48.055 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 198 | 392 | 396 | 1.750 | 2.021 | 3.399 | 6.634 | 5.739 | 2.713 |
| Cash | - | 112 | 797 | 3.634 | 6.583 | 13.225 | 43.026 | 22.885 | 44.524 | 45.342 |
| Shareholders Funds | - | 14 | 896 | 3.633 | 7.915 | 14.898 | 45.974 | 42.201 | 57.036 | 73.585 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 295 | 292 | 398 | 418 | 348 | 451 | 58.568 | 43.471 | 3.759 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hematomed Srl